National Symplicity Study Helps Reach Participant Goal

Medtronic, a world leader in medical device technology, with the involvement of The Heart Hospital at Baylor Plano and the Baylor Jack and Jane Heart and Vascular Hospital at Dallas, finished randomizing the company’s pivotal U.S. clinical trial of the Symplicity™ renal denervation system for treatment-resistant hypertension. Symplicity HTN-3 is Medtronic’s first blinded, randomized, controlled … Continue reading National Symplicity Study Helps Reach Participant Goal